Author: Reuters

By Gene Emery (Reuters Health) – Doctors in Kentucky reported Monday that two of four paralyzed patients were able to walk again with limited assistance after treatment with electrical stimulation to the portion of the...

LONDON (Reuters) – Despite actions taken by companies to prepare for Brexit, there is still a risk of serious supply disruptions for 39 medicines as a result of Britain’s departure from the European Union, the...

By Tamara Mathias (Reuters) – The U.S. Food and Drug Administration on Monday approved Boston Scientific Corp’s drug-coated stent Eluvia to treat narrowed arteries in the leg. The medical device maker intends to...

By Lisa Rapaport (Reuters Health) – Prescription drug shortages may drive up prices twice as much as they would rise with medicines in abundant supply, adding $230 million a year to U.S. drug costs, a new study estimates....

By John Miller ZURICH (Reuters) – Drug giants Novartis, Bayer and Roche on Friday lost a bid to stop British doctors from recommending a cheaper drug option for people with an eye disease that causes blindness, the High...

By Lisa Rapaport (Reuters Health) – A new type of “heat-not-burn” cigarette may lead to just as much lung damage as traditional cigarettes, a recent study suggests. So-called “heat-not-burn” devices...

By Ankur Banerjee (Reuters Health) – The commonly used painkiller diclofenac may be linked with an increased risk of heart problems, a large Danish study suggests. Diclofenac is a non-steroidal anti-inflammatory drug...

SOFIA (Reuters) – An outbreak of a virulent bird flu virus has spread to a farm in southern Bulgaria, the Balkan country’s food safety agency said on Friday. A three-kilometer protection zone was set around the farm...

(Reuters) – Bayer AG’s long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily....